logoTry Persana

YourChoice Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about YourChoice Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

YourChoice Therapeutics company logo

YourChoice Therapeutics is a startup focusing on developing non-hormonal contraceptives for men, highlighted by the introduction of a male birth control pill.

HeadquartersSan Francisco, USA
Team size1-10
Founded2018

What is YourChoice Therapeutics? - Company Overview & Details

YourChoice Therapeutics is YourChoice Therapeutics is a startup focusing on developing non-hormonal contraceptives for men, highlighted by the introduction of a male birth control pill. Founded in 2018, the company is headquartered in San Francisco, USA.

Who Founded YourChoice Therapeutics?

YourChoice Therapeutics is led by CEO Akash Bakshi.

Who are the Key Executives at YourChoice Therapeutics? - Leadership Team

YourChoice Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of YourChoice Therapeutics

Akash BakshiCEO

Chief Technology Officer (CTO) of YourChoice Therapeutics

CTO

About Akash Bakshi - CEO of YourChoice Therapeutics

Akash Bakshi serves as the Chief Executive Officer of YourChoice Therapeutics, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

YourChoice Therapeutics Company Details & Key Information

Where is YourChoice Therapeutics located?

YourChoice Therapeutics is headquartered in San Francisco, USA.

How many employees does YourChoice Therapeutics have?

YourChoice Therapeutics has 1-10 employees.

When was YourChoice Therapeutics founded?

YourChoice Therapeutics was founded in 2018.

YourChoice Therapeutics Official Website

How much funding has YourChoice Therapeutics raised?

YourChoice Therapeutics has raised $15 million across 1 funding rounds. The most recent funding was completed on 2022-07-20.

Funding Overview

YourChoice Therapeutics has raised $15 million in Series A funding to develop new contraceptives for men.

$15 million
Total Funding Raised
1
Funding Rounds
2022-07-20
Latest Round

YourChoice Therapeutics Funding History

Series A
2022-07-20
$15 million

Who are the key investors in YourChoice Therapeutics?

YourChoice Therapeutics is backed by 4 key investors including Future Ventures, North South Ventures, RH Capital. These investors focus on Biotechnology, Healthcare, sectors.

YourChoice Therapeutics Investor Overview

4
Key Investors
3
Focus Areas
0
Notable Investments

Complete List of YourChoice Therapeutics Investors

Future Ventures

Venture capital firm leading the Series A round.

Investment Focus
Biotechnology
Healthcare

North South Ventures

RH Capital

Olive Tree Capital

What sectors do YourChoice Therapeutics investors focus on?

The investors backing YourChoice Therapeutics primarily focus on Biotechnology, Healthcare, sectors.

Biotechnology
Healthcare

Featured Investor: Future Ventures

Future Ventures

Venture capital firm leading the Series A round.

Notable Investments:

What are YourChoice Therapeutics's future plans?

YourChoice Therapeutics YourChoice Therapeutics aims to advance their contraceptive development through human trials and broaden contraceptive options for men.

YourChoice Therapeutics Strategic Outlook

Strategic Focus
Defined
2
Key Challenges
2
Growth Opportunities

What challenges does YourChoice Therapeutics face?

YourChoice Therapeutics has identified 2 key challenges that need to be addressed for continued growth and success.

Key Challenges for YourChoice Therapeutics

1

Funding gaps

2

Scientific challenges in male contraception development

What opportunities does YourChoice Therapeutics have?

YourChoice Therapeutics has identified 2 key opportunities for growth and market expansion.

Growth Opportunities for YourChoice Therapeutics

1

Growing interest in male contraceptive options

2

Potential market demand for non-hormonal contraceptives

YourChoice Therapeutics Strategic Position Summary

Key Focus Areas

YourChoice Therapeutics is addressing 2 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 2 key opportunities for expansion and growth.

What are the latest news about YourChoice Therapeutics?

YourChoice Therapeutics has 2 recent news updates covering key business developments and market activities.

YourChoice Therapeutics News Overview

2
Recent Articles
Active
Media Coverage
2023-12-14
Latest Update

What is YourChoice Therapeutics in the news for?

YourChoice Therapeutics is currently featured in news for Yourchoicetx launches early-stage human clinical trial for male birth control pill. and other significant business developments.

Recent News Articles About YourChoice Therapeutics

Article 1
2023-12-14

Yourchoicetx launches early-stage human clinical trial for male birth control pill.

YourChoice Therapeutics launched an early-stage clinical trial for its male birth control pill YCT-529.

sfstandard.com
Read News
Article 2
2022-07-20

Yourchoicetx receives financing of $15M in Series A.

YourChoice Therapeutics has raised $15 million in Series A funding to develop male contraceptives.

axios.com
Read News

YourChoice Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about YourChoice Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 18 frequently asked questions covering key information about the company.

YourChoice Therapeutics Questions & Answers - Company Information

Q1

What is YourChoice Therapeutics?

YourChoice Therapeutics is a startup focusing on developing non-hormonal contraceptives for men, highlighted by the introduction of a male birth control pill.

Q2

Who founded YourChoice Therapeutics?

YourChoice Therapeutics is led by CEO Akash Bakshi.

Q3

Who is the CEO of YourChoice Therapeutics?

The CEO of YourChoice Therapeutics is Akash Bakshi. You can find more information about them on their LinkedIn profile.

Q4

How much funding has YourChoice Therapeutics raised?

YourChoice Therapeutics has raised a total of $$15 million across 1 funding rounds. The most recent funding was completed on 2022-07-20.

Q5

Who are the investors in YourChoice Therapeutics?

YourChoice Therapeutics's key investors include Future Ventures, North South Ventures, RH Capital, Olive Tree Capital.

Q6

Where is YourChoice Therapeutics headquartered?

YourChoice Therapeutics is headquartered in San Francisco, USA.

Q7

When was YourChoice Therapeutics founded?

YourChoice Therapeutics was founded in 2018.

Q8

How many employees does YourChoice Therapeutics have?

YourChoice Therapeutics has 1-10 employees.

Q9

What is YourChoice Therapeutics's official website?

You can visit YourChoice Therapeutics's official website at https://www.yourchoicetx.com/.

Q10

What was YourChoice Therapeutics's latest funding round?

YourChoice Therapeutics's latest funding round was a Series A round of $$15 million completed on 2022-07-20.

Q11

Who is founder?

Akash Bakshi

Q12

What does the company do?

YourChoice Therapeutics develops non-hormonal contraceptives for men, specifically focusing on a male birth control pill.

Q13

How much funding?

$15 million

Q14

Latest funding date?

2022-07-20

Q15

Who are the investors?

Future Ventures North South Ventures RH Capital Olive Tree Capital

Q16

What are the challenges?

Funding gaps Scientific challenges in male contraception development

Q17

What are the opportunities?

Growing interest in male contraceptive options Potential market demand for non-hormonal contraceptives

Q18

Latest news?

YourChoice Therapeutics launched an early-stage clinical trial for its male birth control pill YCT-529. YourChoice Therapeutics has raised $15 million in Series A funding to develop male contraceptives.

More Information About YourChoice Therapeutics

For additional details about YourChoice Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.